The influence of age, gender and pharmacogenetic profiles on the perspective on medicines in the German EMPAR study
In conclusion, patients' beliefs about medicines and their drug sensitivity perceptions are influenced by various factors including age, gender, previous complications with medicines, and with some tendency also pharmacogenetic profiles. The higher association with more negative views related to treatment indicates that there is a need to target the underlying issues in affected patient groups in order to improve compliance to treatment and outcomes in routine care. Trial registration: EMPAR was registered in the German Clinical Trials Register (DRKS) on 06 July 2018 (DRKS00013909).
Authors
- Michael Steffens (ORCID: https://orcid.org/0000-0002-6445-8593)
- Veronica Atemnkeng Ntam
- Britta Haenisch (ORCID: https://orcid.org/0000-0002-4828-6058)
- Tatjana Huebner (ORCID: https://orcid.org/0000-0003-4548-1234)
- Christoph Roethlein
- Catharina Scholl (ORCID: https://orcid.org/0000-0002-1463-5619)
- Roland Linder (ORCID: https://orcid.org/0000-0001-9568-3331)
- Julia Stingl (ORCID: https://orcid.org/0000-0002-1566-8156)
Institutions
- Federal Institute for Drugs and Medical Devices (DE)
- University of Bonn (DE)
- German Center for Neurodegenerative Diseases (DE)
- Techniker Krankenkasse (Germany) (DE)
- RWTH Aachen University (DE)
Publication Details
- Journal
- PLoS ONE
- Published
- 2024-10-10
- DOI
- https://doi.org/10.1371/journal.pone.0311267
- Citations
- 1
- Primary Topic
- Health Systems, Economic Evaluations, Quality of Life
- Type
- article
- Field-Weighted Citation Impact
- 1.13
Funders
- Gemeinsame Bundesausschuss